About this trial
The goal of this clinical trial is to evaluate whether the Valsalva maneuver reduces invasive pain during arteriovenous fistula (AVF) cannulation in adult hemodialysis patients. The main questions it aims to answer are:
Does the Valsalva maneuver effectively reduce pain intensity during AVF cannulation as measured by the Visual Analogue Scale (VAS)?
Is the Valsalva maneuver feasible, acceptable, and satisfactory for patients, and can it be sustainably implemented over multiple sessions?
Researchers will compare patients performing the Valsalva maneuver (intervention group) with those receiving standard care without any intervention (control group) to see if pain scores are significantly lower and whether patients are willing to continue using this technique voluntarily.
Participants will:
Receive training and supervised practice on the Valsalva maneuver before inclusion in the study
Perform the Valsalva maneuver during AVF cannulation in each hemodialysis session for 12 sessions
Complete VAS pain assessments after each session
Complete a patient satisfaction and feasibility form at the end of the study
Eligibility criteria
Qualifiers
Age 18 years or older
Receiving hemodialysis treatment via arteriovenous fistula for at least 3 months
No analgesic medication use within the past 24 hours
Systolic blood pressure between 90-160 mmHg and diastolic between 60-100 mmHg
Disqualifiers
Unable to correctly perform the Valsalva maneuver
Failed first cannulation attempt
History of acute myocardial infarction or malignant arrhythmia
Aneurysm, infection, edema, or scar tissue at AVF site
Trial design
Treatments tested in this trial
- Valsalva Maneuver
Treatment groups
Locations
Sponsors and collaborators
Cansu POLAT DÜNYA
Lead sponsor
Istanbul University
Sponsor institution
Istanbul University Scientific Research Projects Coordination Unit- Pending
Collaborator